Phase 2 Type 1 Diabetes Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Be between 10 and 17 years old
- Have been diagnosed with stage 3 Type 1 Diabetes (T1D), meaning blood sugar levels are high enough to meet standard diabetes diagnosis guidelines
- Be able to start the study treatment within 21 days of their diabetes diagnosis (counting from the first insulin dose)
- Have lung function test results showing the lungs are working at more than 80% of the expected level for their age and size
- Be someone the study doctor believes can follow the study rules and schedule
- Have no health conditions, mental health conditions, or current medications that the study doctor thinks would make participation unsafe
Who may not be able to join:
- Have already received insulin treatment for an earlier stage (stage 2) of Type 1 Diabetes
- Have a history of ongoing lung conditions such as asthma, chronic obstructive pulmonary disease (COPD), lung cancer, cystic fibrosis, or other significant lung diseases (confirm with trial site)
- Have an allergy or known reaction to human regular insulin
- Have smoked or vaped (including cigarettes, cigars, pipes, or marijuana) in the 3 months before screening, or test positive for a substance that shows recent smoking
- Have a positive pregnancy test, if female and able to become pregnant
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 818-661-5032
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Percentage of participants with Continuous Glucose Meter (CGM) measured time in range (TIR) ≥70%
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.